Black Rock Inc. Revance Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,565,317 shares of RVNC stock, worth $22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,565,317

Previous 7,312,479 17.13%

Holding current value

$22 Million

Previous $36 Million 38.82%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.34 - $4.73 $2.93 Million - $5.93 Million	1,252,838 Added 17.13%	8,565,317 $22 Million
Q1 2024 May 10, 2024	SELL	$4.65 - $9.31 $655,147 - $1.31 Million	-140,892 Reduced 1.89%	7,312,479 $36 Million
Q4 2023 Feb 13, 2024	BUY	$5.81 - $11.2 $4.05 Million - $7.8 Million	696,651 Added 10.31%	7,453,371 $65.5 Million
Q3 2023 Nov 13, 2023	BUY	$11.47 - $25.07 $2.64 Million - $5.77 Million	230,132 Added 3.53%	6,756,720 $77.5 Million
Q2 2023 Aug 11, 2023	BUY	$24.7 - $37.61 $9.57 Million - $14.6 Million	387,524 Added 6.31%	6,526,588 $165 Million
Q1 2023 May 12, 2023	SELL	$18.36 - $35.27 $17.2 Million - $33 Million	-934,799 Reduced 13.21%	6,139,064 $198 Million
Q4 2022 Feb 13, 2023	BUY	$18.32 - $30.66 $17.3 Million - $28.9 Million	942,047 Added 15.36%	7,073,863 $131 Million
Q3 2022 Nov 14, 2022	BUY	$14.33 - $28.47 $6.41 Million - $12.7 Million	446,985 Added 7.86%	6,131,816 $166 Million
Q2 2022 Aug 12, 2022	BUY	$11.52 - $20.4 $4.58 Million - $8.11 Million	397,683 Added 7.52%	5,684,831 $78.6 Million
Q1 2022 May 12, 2022	SELL	$12.36 - $20.31 $580,314 - $953,574	-46,951 Reduced 0.88%	5,287,148 $103 Million
Q4 2021 Feb 10, 2022	SELL	$12.46 - $27.87 $465,605 - $1.04 Million	-37,368 Reduced 0.7%	5,334,099 $87.1 Million
Q3 2021 Nov 09, 2021	BUY	$25.78 - $33.21 $613,280 - $790,032	23,789 Added 0.44%	5,371,467 $150 Million
Q2 2021 Aug 11, 2021	BUY	$26.8 - $31.84 $143 Million - $170 Million	5,347,678 New	5,347,678 $159 Million

Others Institutions Holding RVNC

# of Institutions

Shares Held

10.1M

Call Options Held

360K

Put Options Held

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account